Sort
4,870 grants matching “glp 1”
Project 1 - Profectus Biosciences, Inc.
$802,301John H Eldridge · Henry M. Jackson Fdn For The Adv Mil/Med · U19 · FY2022 · AI
Core C - The University of Texas Medical Branch at Galveston
$802,301Thomas William Geisbert · Henry M. Jackson Fdn For The Adv Mil/Med · U19 · FY2022 · AI
Long-acting Antiviral Treatment for HBV
$799,938Rodney J.y. Ho · University Of Washington · R01 · FY2025 · AI
CometChip: Development of a high throughput DNA damage assay in hepatocytes
$799,905Leslie Recio · Integrated Laboratory Systems, Llc · U44 · FY2019 · ES
CometChip: Development of a high throughput DNA damage assay in hepatocytes
$799,905Carol D. Swartz · Integrated Laboratory Systems, Llc · U44 · FY2020 · ES
RP1: rVSV Vectored Vaccine to Treat Ebola and Marburg Infection
$797,292John H Eldridge · University Of Texas Med Br Galveston · U19 · FY2015 · AI
Auto-Injectable Diazepam Formulation for Rapid Treatment of Uncontrolled Seizures
$797,247Steven Prestrelski · Xeris Pharmaceuticals, Inc. · R44 · FY2017 · NS
Manufacturing of Novel Adenovirus Prime-Boost HIV-1 Vaccine
$796,534Jaap Goudsmit · Beth Israel Deaconess Medical Center · U19 · FY2011 · AI
Affordable Oral Delivery of Human Therapeutic Proteins Bioencapsulated in Plant Cells
$795,892Henry Daniell · University Of Pennsylvania · R01 · FY2020 · HL
A Simple and Implantable Device for the Treatment of Gastroesophageal Reflux Disease
$795,705Claude Nmn Tihon · Aplos Medical Inc · R44 · FY2016 · DK
"NextGen Long-acting Platform: Targeted Combination Antiretrovirals"
$794,929Ann Cornwall Collier · University Of Washington · U01 · FY2019 · AI
Auto-Injectable Diazepam Formulation for Rapid Treatment of Uncontrolled Seizures
$793,851Steven Prestrelski · Xeris Pharmaceuticals, Inc. · R44 · FY2018 · NS
Epigenetic Reprogramming in HIV-Associated Cardio-Vascular Disease
$793,579Michael Ilya Bukrinsky · George Washington University · R01 · FY2019 · HL
The optimization of compounds that selectively inhibit protein synthesis for the
$792,608Cathy A Swindlehurst · Novomedix, Inc. · R44 · FY2012 · CA
Novel approaches to improve comparative effectiveness research of medical and surgical weight reduction strategies in clinical practice
$792,374Elisabetta Patorno · Brigham And Women'S Hospital · R01 · FY2024 · DK
NP855 for Targeting Thyrointegrin αvβ3 receptors and Norepinephrine Transporter in Neuroblastoma Management
$792,367Paul Davis · Nanopharmaceuticals, Llc · R44 · FY2024 · CA
Human antibodies for therapeutic intervention of staph enterotoxin B exposure
$792,333Luigi Grasso · Morphotek, Inc. · U01 · FY2007 · AI
Changes in Body Composition including Muscle with Anti-Obesity Medications, both with and without Exercise
$789,684John M Jakicic · University Of Kansas Medical Center · R01 · FY2025 · DK
CENTER FOR RECOMBINANT GAMETE CONTRACEPTIVE VACCINOGENS
$789,309University Of Virginia Charlottesville · U54 · FY2002 · HD
Effects of GLP-l receptor agonists on cardiometabolic alterations in HIV-associated lipohypertrophy
$788,897Grace A McComsey · Case Western Reserve University · R01 · FY2019 · DK
Inhalational therapy with spectinamides within new regimens of TB therapy
$788,086Mercedes Gonzalez-Juarrero · Colorado State University · R01 · FY2025 · AI
Development of a High Efficiency Plasma Sterilizer
$787,734Brian C Brosdahl · Sterilucent, Inc. · R44 · FY2007 · HL
Epigenetic Reprogramming in HIV-Associated Cardio-Vascular Disease
$787,681Michael Ilya Bukrinsky · George Washington University · R01 · FY2018 · HL
Targeted delivery of Lu-177 to tumor vasculature
$786,124Joseph M Backer · Sibtech, Inc. · R44 · FY2011 · CA
Affordable Oral Delivery of Human Therapeutic Proteins Bioencapsulated in Plant Cells
$785,508Henry Daniell · University Of Pennsylvania · R01 · FY2021 · HL